medRxiv
Updating Insights into Rosiglitazone and Cardiovascular Risk through Shared Data: Individual Patient- and Summary-Level Meta-Analyses
Publication
, Preprint
Wallach, J; Wang, K; Zhang, A; Cheng, D; Grossetta Nardini, H; Lin, H; Bracken, M; Desai, M; Krumholz, H; Ross, J
2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Wallach, J., Wang, K., Zhang, A., Cheng, D., Grossetta Nardini, H., Lin, H., … Ross, J. (2019). Updating Insights into Rosiglitazone and Cardiovascular Risk through Shared Data: Individual Patient- and Summary-Level Meta-Analyses. medRxiv. https://doi.org/10.1101/19000463
Wallach, Joshua, Kun Wang, Audrey Zhang, Deanna Cheng, Holly Grossetta Nardini, Haiqun Lin, Michael Bracken, Mayur Desai, Harlan Krumholz, and Joseph Ross. “Updating Insights into Rosiglitazone and Cardiovascular Risk through Shared Data: Individual Patient- and Summary-Level Meta-Analyses.” MedRxiv, 2019. https://doi.org/10.1101/19000463.
Wallach J, Wang K, Zhang A, Cheng D, Grossetta Nardini H, Lin H, et al. Updating Insights into Rosiglitazone and Cardiovascular Risk through Shared Data: Individual Patient- and Summary-Level Meta-Analyses. medRxiv. 2019.
Wallach, Joshua, et al. “Updating Insights into Rosiglitazone and Cardiovascular Risk through Shared Data: Individual Patient- and Summary-Level Meta-Analyses.” MedRxiv, 2019. Epmc, doi:10.1101/19000463.
Wallach J, Wang K, Zhang A, Cheng D, Grossetta Nardini H, Lin H, Bracken M, Desai M, Krumholz H, Ross J. Updating Insights into Rosiglitazone and Cardiovascular Risk through Shared Data: Individual Patient- and Summary-Level Meta-Analyses. medRxiv. 2019.